Sign Up to like & get recommendations! 0
Published in 2018 at "International Journal of Cancer"
DOI: 10.1002/ijc.31768
Abstract: Women with endometriosis, a benign growth of endometrial tissue outside the uterine cavity, are at increased risk of specific histotypes of epithelial ovarian cancer, such as ovarian endometrioid adenocarcinoma (OEA). Women with OEA who have… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Gynecologic Oncology Reports"
DOI: 10.1016/j.gore.2019.01.001
Abstract: Ovarian endometrioid adenocarcinoma with yolk sac component has been reported in fewer than twenty cases in the literature. A majority of the diagnoses are described in postmenopausal women without specific reference to germline genetic testing.… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Human pathology"
DOI: 10.1016/j.humpath.2017.07.003
Abstract: Endometrial intraepithelial neoplasia (EIN) and atypical endometrial hyperplasia (AH) are histomorphologically defined precursors to endometrioid adenocarcinoma, which are unified as EIN/AH by the World Health Organization. EIN/AH harbors a constellation of molecular alterations similar to… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Seminars in diagnostic pathology"
DOI: 10.1053/j.semdp.2022.02.002
Abstract: Endometrioid adenocarcinoma (ECa) may feature a number of morphologic variations that can pose diagnostic challenge. The purpose of this review and update is to examine the spectrum of morphologic variants and mimics of low-grade (FIGO… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "International Journal of Gynecological Pathology"
DOI: 10.1097/pgp.0000000000000671
Abstract: Corded and hyalinized endometrioid adenocarcinoma (CHEC) is a morphologic variant of endometrioid adenocarcinoma that is typically low-grade [International Federation of Gynecology and Obstetrics (FIGO) grade 1-2]. CHEC exhibits a biphasic appearance with gland forming adenocarcinoma… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Clinical nuclear medicine"
DOI: 10.1097/rlu.0000000000001694
Abstract: Endometrial cancer, a common cancer affecting women, has the tendency to metastasize to the lung and liver. Bone metastases in endometrial cancers are rare and accounts for less than 1% of the overall incidence of… read more here.
Sign Up to like & get recommendations! 1
Published in 2021 at "International Journal of Gynecological Cancer"
DOI: 10.1136/ijgc-2021-002380
Abstract: Background The optimal treatment of patients with FIGO stage IB grade 3 endometrial endometrioid adenocarcinoma remains unknown. Objective To compare overall survival following treatment with a hysterectomy and adjuvant radiotherapy with or without chemotherapy in… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "European review for medical and pharmacological sciences"
DOI: 10.26355/eurrev_201801_14100
Abstract: OBJECTIVE This study aimed to investigate the role of NEDD9 (neural precursor cell expressed developmentally down-regulated 9), BCAR1/P130CAS (BCAR1/P130 Crk-associated substrate) and paxillin in predicting the prognosis of endometrioid adenocarcinoma (EA), so as to guild… read more here.
Sign Up to like & get recommendations! 1
Published in 2021 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.692282
Abstract: Objective The curative effect of high-efficiency progesterone and other therapeutic drugs for endometrioid adenocarcinoma patients with preservation of reproductive capacity has not been satisfactory so far. Novel therapeutic drugs need to be explored. Methods We… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.950589
Abstract: Purpose To investigate the association between subtypes of metabolic syndrome (MetS) and prognosis of patients with stage I endometrioid adenocarcinoma. Patients and methods Patients with stage I endometrioid adenocarcinoma who received surgical treatment as primary… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.951573
Abstract: Background Endometrioid adenocarcinoma (EAC) is the most common subtype of endometrial cancer (EC) and is an estrogen-related cancer. In this study, we sought to investigate the expressions and mechanism of action of 17β-estradiol (E2) and… read more here.